Biallelic expression of the H19 and IGF2 genes in hepatocellular carcinoma

Cancer Letters

Volumn 119, Issue 2, 1997, Pages 143-148

  Kim, Kyoung Sook ^a   Lee, Young Ik ^a  

^a Korea Institute of Science and Technology   (South Korea)

Author keywords

H19 gene; Hep3B; Hepatocellular carcinoma (HCC); Insulin like growth factor II (IGF2); Loss of imprinting (LOI)

Indexed keywords

SOMATOMEDIN B;

ALLELE; ARTICLE; CASE REPORT; CONTROLLED STUDY; DOWN REGULATION; GENE; GENE EXPRESSION; GENOME IMPRINTING; HEPATOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; PRIORITY JOURNAL; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

CARCINOMA, HEPATOCELLULAR; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOMIC IMPRINTING; HUMANS; INSULIN-LIKE GROWTH FACTOR II; LIVER NEOPLASMS; MUSCLE PROTEINS; RNA, UNTRANSLATED; TUMOR CELLS, CULTURED;

EID: 0030715240     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)00264-4     Document Type: Article

References (28)

1. C.N. d'Arville, K.T. Noun-Aria, P. Johnson, R. Williams, Regulation of insulin-like growth factor II gene expression by hepatitis B virus in hepatocellular carcinoma, Hepatology 13 (1991) 310-315.
2. M.S. Bartolomei, S. Zemel, S.M. Tilghman, Parental imprinting of the mouse H19 gene, Nature 351 (1995) 153-155.
3. C.I. Brannon, E.C. Dees, R.S. Ingrain, S.M. Tilghman, The product of the H19 gene may function as an RNA, Mol. Cell. Biol. 10 (1990) 28-36.
4. E. Cariani, C. Lasserre, D. Seurin, B. Hamelin, F. Kemeny, D. Franco, M.P. Czech, A. Ullrich, C. Brechot, Differential expression of insulin-like growth factor II mRNA in human primary liver cancers, benign liver tumors, and liver cirrhosis, Cancer Res. 48 (1988) 6844-6849.
5. P. Chomczyski, N. Sacchi, Single-step method of RNA isolation by acid guanidinium thiocynate-phenol-chloroform extraction, Anal. Biochem. 162 (1987) 156-159.
6. S.M. Davies, Maintenance of genomic imprinting at the IGF2 locus in hepatoblastoma, Cancer Res. 53 (1993) 4781-4783.
7. T.M. DeChiara, E.J. Robertson, A. Efstratiadis, Parental imprinting of the mouse insulin-like growth factor II gene, Cell 64 (1991) 849-859.
8. W. Engstrom, S. Lindham, P. Schofield, Wiedmann-Beckwith syndrome, Eur. J. Pediatr. 147 (1988) 450-457.
9. X.X. Fu, C.Y. Su, Y.I. Lee, R. Hintz, L. Biempica, R. Snyder, C.E. Rogler, Insulin-like growth factor II expression and overall cell proliferation associated with hepatocarcinogenesis in woodchuck hepatitis virus carriers, J. Virol. 62 (1988) 3422-3430.
10. R.J.H.L.M. van Gurp, J.W. Oosterhuis, V. Kalscheuer, E.C.M. Mariman, L.H.J. Looijenga, Biallelic expression of the H19 and IGF2 genes in human testicular germ cell tumors, J. Natl. Cancer Inst. 86 (1994) 1070-1075.
11. Y. Hao, T. Crenshaw, T. Moulton, E. Newcomb, B. Tycko, Tumour-suppressor activity of H19 RNA, Nature 364 (1993) 764-767.
12. K. Hashimoto, C. Azuma, M. Koyama, K. Ohashi, S. Kamiura, T. Nobunaga, T. Kimura, Y. Tokugawa, T. Kanai, F. Saji, Loss of imprinting in choriocarcinoma, Nat. Genet. 9 (1995) 109-110.
13. J.E. Lee, J. Pintar, A. Efstratiadis, Pattern of the insulin-like growth factor II gene expression during early mouse embryogenesis, Development 110 (1990) 151-159.
14. T. Moulton, T. Crenshaw, Y. Hao, J. Moosikasusan, N. Lin, F. Dembitzer, T. Hensle, L. Weiss, L. McMorrow, T. Loew, W. Draus, W. Gerald, B. Tycko, Epigenetic lesions at the H19 locus in Wilms' tumor patients, Nat. Genet. 7 (1994) 440-447.
15. O. Ogawa, M.R. Eccles, J. Szeto, L.A. McNoe, K. Yun, M.A. Maw, P.J. Smith, A.E. Reeve, Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumor, Nature 362 (1993) 749-751.
16. A.J. Ping, A.E. Reeve, D.J. Law, M.D. Young, M. Boehnke, A.P. Feinberg, Genetic linkage of Beckwith-Wiedmann syndrome to 11P, Am. J. Hum. Genet. 44 (1989) 720-723.
17. S. Rainier, C.J. Dobry, A.P. Feinberg, Loss of imprinting in hepatoblastoma, Cancer Res. 55 (1995) 1836-1838.
18. S. Rainier, L.A. Johnson, C.J. Dobry, A.J. Ping, P.E. Grundy, A.P. Feinberg, Relaxation of imprinted genes in human cancer, Nature 362 (1993) 747-749.
19. C. Sapienza, Genome imprinting: an overview, Dev. Genet. 17 (1995) 85-187.
20. M.J.C. Steenman, S. Rainier, C.J. Dobry, P. Grundy, I. Horon, A.P. Feinberg, Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumor, Nat. Genet. 7 (1994) 433-439.
21. H. Suzuki, R. Ueda, T. Takahashi, T. Takahashi, Altered imprinting in lung cancer, Nat. Genet. 6 (1994) 332-333.
22. E. Tabor, Strongly supported features of the association between hepatitis B virus and hepatocellular carcinoma, in: E. Tabor, A.M. Di Bisceglie, R.H. Purcell (Eds.), Etiology, Pathology, and Treatment of Hepatocellular Carcinoma in North America, The Woodlands, TX, 1991, pp. 107-117.
23. E. Tabor, Tumor suppressor genes, growth factor genes, and oncogenes in hepatitis B virus-associated hepatocellular carcinoma, J. Med. Virol. 42 (1994) 357-365.
24. K. Tadokoro, H. Fujii, T. Inoue, M. Yamada, Polymerase chain detection of ApaI polymorphism at the insulin-like growth factor II gene (IGF2), Nucleic Acids Res. 19 (1991) 6967-6970.
25. T.H. Vu, A.R. Hoffman, Promoter-specific imprinting of the human insulin-like growth factor-II gene, Nature 371 (1994) 714-717.
26. S. Zemel, M.S. Bartolomei, S.M. Tilghman, Physical linkage of two mammalian imprinted genes, H19 and insulin-like growth factor 2, Nat. Genet. 2 (1992) 61-65.
27. S. Zhan, N. Shapiro, L.J. Helman, Activation of an imprinting allele of the insulin-like growth factor II gene implicated in rhabdomyosarcoma, J. Clin. Invest. 94 (1994) 445-448.
28. Y. Zhang, B. Tyoko, Monoallelic expression of the human H19 gene, Nat. Genet. 1 (1992) 40-44.